News

Coldizin will be sold under private label as a food supplement, and marketed throughout the country through Negma’s sales and marketing organization. The launch is planned for the

The 10 year agreement with Wockhardt in India initially covers: Atopiclair – non steroidal cream for atopic dermatitis, Aloclair – presentations for the treatment of mouth ulcers, Papulex

Under the terms of the agreement, Norgine is granted an exclusive licence to develop and market Colal-Pred in Europe, South Africa, Australia and New Zealand. Alizyme will immediately

The patent protects technology which improves HbA1c stability, precision and accuracy and has resulted in a longer product shelf-life with improved performance. The invention may also have utility

The Phase IIa, double-blind, placebo-controlled clinical study in 124 patients with mild to moderate hypertension has been initiated in the UK. Patients will be given a course of

The positive opinion is based upon the results of five clinical studies – four double-blind placebo-controlled studies and a relapse prevention study – involving more than 2,000 non-depressed

Aerocrine’s method of measuring airway inflammation, using exhaled nitric oxide (NO) tests, has also been incorporated into China’s national guidelines for asthma management. The new guidelines have resulted

Integra’s Tibiaxys plating system has received clearance from the FDA, and a CE Mark certification in the European Union. According to Integra, the Tibiaxys system is designed specifically

The supplemental biologics license application (sBLA) seeks to convert an accelerated approval indication into full approval. It is based on a placebo-controlled Phase III clinical trial to confirm